Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles.

Gazinska P, Grigoriadis A, Brown JP, Millis RR, Mera A, Gillett CE, Holmberg LH, Tutt AN, Pinder SE.

Mod Pathol. 2013 Jul;26(7):955-66. doi: 10.1038/modpathol.2012.244. Epub 2013 Feb 8.

2.

Epitheliosis, infiltrating epitheliosis, and radial scar.

Eusebi V, Millis RR.

Semin Diagn Pathol. 2010 Feb;27(1):5-12.

PMID:
20306826
3.

Different patterns of inflammation and prognosis in invasive carcinoma of the breast.

Lee AH, Gillett CE, Ryder K, Fentiman IS, Miles DW, Millis RR.

Histopathology. 2006 May;48(6):692-701.

PMID:
16681685
4.

An alternative method of dissecting mastectomy specimens.

D'Arrigo C, Hanby AM, Springall RJ, Gillett CE, Millis RR.

Histopathology. 2006 Apr;48(5):608-9. No abstract available.

PMID:
16623789
5.

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast.

Millis RR, Pinder SE, Ryder K, Howitt R, Lakhani SR.

Br J Cancer. 2004 Apr 19;90(8):1538-42.

6.

Ductal in situ component and prognosis in invasive mammary carcinoma.

Millis RR, Ryder K, Fentiman IS.

Breast Cancer Res Treat. 2004 Mar;84(2):197-8. No abstract available.

PMID:
15069931
7.
8.

A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.

Millis RR, Springall RJ, Hanby AM, Ryder K, Fentiman IS.

Cancer. 2002 Apr 15;94(8):2307-9. No abstract available.

9.

Occult axillary lymph node metastases are of no prognostic significance in breast cancer.

Millis RR, Springall R, Lee AH, Ryder K, Rytina ER, Fentiman IS.

Br J Cancer. 2002 Feb 1;86(3):396-401.

10.

Minimal breast cancer: evaluation of histology and biological marker expression.

Dublin EA, Millis RR, Smith P, Bobrow LG.

Br J Cancer. 1999 Jul;80(10):1608-16.

11.

Expression of c-erbB2 and p53 protein is similar in breast cancer from British and Japanese women.

Merchant WJ, Millis RR, Smith P, Chaudary MA, Barnes DM.

Int J Cancer. 1999 Jun 21;84(3):278-83.

12.

Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance.

Barnes DM, Millis RR, Beex LV, Thorpe SM, Leake RE.

Eur J Cancer. 1998 Oct;34(11):1677-82. Review.

PMID:
9893651
13.

Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up.

Badve S, A'Hern RP, Ward AM, Millis RR, Pinder SE, Ellis IO, Gusterson BA, Sloane JP.

Hum Pathol. 1998 Sep;29(9):915-23.

PMID:
9744307
14.

Tumour grade does not change between primary and recurrent mammary carcinoma.

Millis RR, Barnes DM, Lampejo OT, Egan MK, Smith P.

Eur J Cancer. 1998 Mar;34(4):548-53.

PMID:
9713307
15.

Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia.

Gillett CE, Lee AH, Millis RR, Barnes DM.

J Pathol. 1998 Apr;184(4):396-400.

PMID:
9664905
16.

Family history and survival in premenopausal breast cancer.

Mohammed SN, Smith P, Hodgson SV, Fentiman IS, Miles DW, Barnes DM, Millis RR, Rubens RD.

Br J Cancer. 1998 Jun;77(12):2252-6.

17.

Adenomyoepithelioma of the breast with malignant features.

Rasbridge SA, Millis RR.

Virchows Arch. 1998 Feb;432(2):123-30.

PMID:
9504856
18.

c-erbB-3 protein expression in ductal carcinoma in situ of the breast.

Bobrow LG, Millis RR, Happerfield LC, Gullick WJ.

Eur J Cancer. 1997 Oct;33(11):1846-50.

PMID:
9470844
19.

Angiogenesis and inflammation in invasive carcinoma of the breast.

Lee AH, Happerfield LC, Bobrow LG, Millis RR.

J Clin Pathol. 1997 Aug;50(8):669-73.

20.

Angiogenesis and inflammation in ductal carcinoma in situ of the breast.

Lee AH, Happerfield LC, Bobrow LG, Millis RR.

J Pathol. 1997 Feb;181(2):200-6.

PMID:
9120726
21.

Mucoid breast carcinomas: histology and prognosis.

Fentiman IS, Millis RR, Smith P, Ellul JP, Lampejo O.

Br J Cancer. 1997;75(7):1061-5.

22.

Body weight and vascular invasion in post-menopausal women with breast cancer.

Badwe RA, Fentiman IS, Millis RR, Gregory WM.

Br J Cancer. 1997;75(6):910-3.

23.

Histopathology of breast cancer in relation to age.

Fisher CJ, Egan MK, Smith P, Wicks K, Millis RR, Fentiman IS.

Br J Cancer. 1997;75(4):593-6.

26.

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.

Lee AH, Happerfield LC, Millis RR, Bobrow LG.

Br J Cancer. 1996 Sep;74(5):796-801.

27.

Sclerosing lymphocytic lobulitis in the male breast.

Lee AH, Zafrani B, Kafiri G, Rozan S, Millis RR.

J Clin Pathol. 1996 Jul;49(7):609-11.

28.

One and two view mammography in breast cancer. Are carcinomas detected by one and two view mammography similar?

Lee AH, Borrow LG, Millis RR.

BMJ. 1996 Feb 24;312(7029):508-9; author reply 509-10. No abstract available.

29.

Lymphocytic lobulitis and carcinoma of the breast.

Lee AH, Millis RR, Bobrow LG.

Histopathology. 1996 Jan;28(1):94-5. No abstract available.

PMID:
8838131
30.

Cyclical tumour variations in premenopausal women with early breast cancer.

Badwe RA, Bettelheim R, Millis RR, Gregory W, Richards MA, Fentiman IS.

Eur J Cancer. 1995 Dec;31A(13-14):2181-4.

PMID:
8652239
31.

Carcinoma in situ involving sclerosing adenosis: a mimic of invasive breast carcinoma.

Rasbridge SA, Millis RR.

Histopathology. 1995 Sep;27(3):269-73.

PMID:
8522292
32.

Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers.

Bobrow LG, Happerfield LC, Gregory WM, Millis RR.

J Pathol. 1995 Aug;176(4):333-41.

PMID:
7562248
33.
34.

The pathology of ductal carcinoma in situ of the breast.

Bobrow LG, Millis RR.

Clin Oncol (R Coll Radiol). 1995;7(4):232-5. Review. No abstract available.

PMID:
8845318
35.

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.

Camplejohn RS, Ash CM, Gillett CE, Raikundalia B, Barnes DM, Gregory WM, Richards MA, Millis RR.

Br J Cancer. 1995 Jan;71(1):140-5.

36.

Primary lymphoma of the breast and lymphocytic lobulitis.

Lee AH, Millis RR, Bobrow LG.

Histopathology. 1994 Sep;25(3):297-8. No abstract available.

PMID:
7821902
37.

The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma.

Rasbridge SA, Gillett CE, Seymour AM, Patel K, Richards MA, Rubens RD, Millis RR.

Br J Cancer. 1994 Aug;70(2):335-41.

39.

The classification of ductal carcinoma in situ and its association with biological markers.

Bobrow LG, Happerfield LC, Gregory WM, Springall RD, Millis RR.

Semin Diagn Pathol. 1994 Aug;11(3):199-207.

PMID:
7831531
40.

Ductal carcinoma in situ: a proposal for a new classification.

Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B.

Semin Diagn Pathol. 1994 Aug;11(3):167-80. Review.

PMID:
7831528
41.

Benign lymph node inclusions mimicking metastatic carcinoma.

Fisher CJ, Hill S, Millis RR.

J Clin Pathol. 1994 Mar;47(3):245-7.

42.

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.

Fisher CJ, Gillett CE, Vojtĕsek B, Barnes DM, Millis RR.

Br J Cancer. 1994 Jan;69(1):26-31.

43.

Adenoma of the nipple: a diagnostic dilemma.

Vianna LL, Millis RR, Fentiman IS.

Br J Hosp Med. 1993 Dec 15-1994 Jan 18;50(11):639-42. Review.

PMID:
8124544
44.

Age as prognostic factor in premenopausal breast cancer.

Richards MA, Gregory WM, Smith P, Millis RR, Fentiman IS, Rubens RD.

Lancet. 1993 Jun 5;341(8858):1484-5. No abstract available.

PMID:
8099185
45.

Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?

Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR.

Hum Pathol. 1993 May;24(5):469-76.

PMID:
7684021
46.

Oestrogen and progesterone receptor expression in mammary fibromatosis.

Rasbridge SA, Gillett CE, Millis RR.

J Clin Pathol. 1993 Apr;46(4):349-51.

47.

Breast lymphomas: a clinicopathologic review.

Bobrow LG, Richards MA, Happerfield LC, Diss TC, Isaacson PG, Lammie GA, Millis RR.

Hum Pathol. 1993 Mar;24(3):274-8. Review.

PMID:
8454272
48.

Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison.

Eusebi V, Foschini MP, Betts CM, Gherardi G, Millis RR, Bussolati G, Azzopardi JG.

Am J Surg Pathol. 1993 Feb;17(2):99-109.

PMID:
8422116
49.

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.

Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR.

J Pathol. 1993 Feb;169(2):245-50.

PMID:
8383197
50.

Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours.

Bartkova J, Bartek J, Vojtesek B, Lukas J, Rejthar A, Kovarik J, Millis RR, Lane DP, Barnes DM.

Eur J Cancer. 1993;29A(6):881-6.

PMID:
8484983

Supplemental Content

Loading ...
Support Center